Cite

HARVARD Citation

    Hewitt, D. et al. (2013). Long‐Term Open‐Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs. Headache. 53 (1), pp. 104-117. [Online]. 
  
Back to record